Cellosaurus logo
expasy logo

Cellosaurus LL1 (CVCL_C4MN)

[Text version]
Cell line name LL1
Synonyms EPB-1; EPB1
Accession CVCL_C4MN
Resource Identification Initiative To cite this cell line use: LL1 (RRID:CVCL_C4MN)
Comments Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized milatuzumab (hLL1; MEDI-115) therapeutic antibody used for the treatment of multiple myeloma, non-Hodgkin's lymphoma and chronic lymphocytic leukemia. When conjugated with doxorubicin, milatuzumab is known as IMMU-110 (hLL1-Dox) and is used for the treatment of relapsed multiple myeloma.
Monoclonal antibody isotype: IgG1, kappa.
Monoclonal antibody target: UniProtKB; P04233; Human CD74.
Species of origin Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Hierarchy Parent: CVCL_2199 (Sp2/0-Ag14)
Category Hybridoma
Publications

PubMed=2663143
Pawlak-Byczkowska E.J., Hansen H.J., Dion A.S., Goldenberg D.M.
Two new monoclonal antibodies, EPB-1 and EPB-2, reactive with human lymphoma.
Cancer Res. 49:4568-4577(1989)

PubMed=8947500; DOI=10.1042/bj3200293; PMCID=PMC1217930
Hansen H.J., Ong G.L., Diril H., Valdez A., Roche P.A., Griffiths G.L., Goldenberg D.M., Mattes M.J.
Internalization and catabolism of radiolabelled antibodies to the MHC class-II invariant chain by B-cell lymphomas.
Biochem. J. 320:293-300(1996)

Cross-references
Biological sample resources ABCD; ABCD_AD421
Encyclopedic resources Wikidata; Q116049709
Entry history
Entry creation15-Dec-2022
Last entry update21-Mar-2023
Version number2